D Naber. Show Affiliations »
Abstract
Mesh： See more » Acute DiseaseAmisulprideAntipsychotic Agents/economicsAntipsychotic Agents/therapeutic useBenzodiazepinesClozapine/therapeutic useCost-Benefit AnalysisDibenzothiazepines/therapeutic useDibenzothiepins/therapeutic useDyskinesia, Drug-Induced/prevention & controlGermanyHumansNeurotransmitter Agents/economicsNeurotransmitter Agents/therapeutic useOlanzapinePatient CompliancePirenzepine/analogs & derivativesPirenzepine/therapeutic useQuetiapine FumarateRandomized Controlled Trials as TopicRisperidone/therapeutic useSchizophrenia/drug therapySchizophrenia/economicsSulpiride/analogs & derivativesSulpiride/therapeutic use
Substances： See more » Antipsychotic AgentsDibenzothiazepinesDibenzothiepinsNeurotransmitter AgentsBenzodiazepinesQuetiapine FumaratePirenzepineSulpirideAmisulprideClozapineRisperidoneOlanzapinezotepine
Year: 2000 PMID： 10846707 DOI： 10.1007/s001150050566
Source DB: PubMed Journal: Nervenarzt ISSN： 0028-2804 Impact factor: 1.214